Member Publications

Alkhani A, Baskaran S, Murti A, Rapp B, Levy CS, Wang B, Nijagal A. Perinatal liver inflammation is associated with persistent elevation of CXCL10 and its canonical receptor CXCR3 on common myeloid progenitors. bioRxiv [Preprint]. 2024 Aug 19:2024.08.15.607661. doi: 10.1101/2024.08.15.607661. PMID: 39229070; PMCID: PMC11370417.

Allende DS, Cummings O, Sternberg AL, Behling CA, Carpenter D, Gill RM, Guy CD, Yeh MM, Gawrieh S, Sterling RK, Naggie S, Loomba R, Price JC, McLaughlin M, Hadigan C, Crandall H, Belt P, Wilson L, Chalasani NP, Kleiner DE; HIV NASH and NASH Clinical Research Groups. MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls. Aliment Pharmacol Ther. 2024 Sep 5. doi: 10.1111/apt.18236. Epub ahead of print. PMID: 39238213.

Benet LZ, Tiitto MV, Sodhi JK. The potential of developing high hepatic clearance drugs via controlled release: Lessons from Kirchhoff's Laws. J Control Release. 2024 Sep;373:564-567. doi: 10.1016/j.jconrel.2024.07.040. Epub 2024 Jul 29. PMID: 39032574.

Bragg-Gresham JL, Peters TG, Vaughan WP, Held P, McCormick F, Roberts JP. The Cost of Procuring Deceased Donor Livers: Evidence From US Organ Procurement Organization Cost Reports, 2013-2018. Clin Transplant. 2024 Sep;38(9):e15452. doi: 10.1111/ctr.15452. PMID: 39238430.

Cama-Olivares A, Ouyang T, Takeuchi T, St Hillien SA, Robinson JE, Chung RT, Cullaro G, Karvellas CJ, Levitsky J, Orman ES, Patidar KR, Regner KR, Saly DL, Sawinski D, Sharma P, Teixeira JP, Ufere NN, Velez JCQ, Wadei HM, Wahid N, Allegretti AS, Neyra JA, Belcher JM; HRS-HARMONY Consortium. Association of HRS-AKI with Mortality in Patients with Cirrhosis Requiring Renal Replacement Therapy: Results from the HRS-HARMONY Consortium. Kidney360. 2024 Sep 30. doi: 10.34067/KID.0000000589. Epub ahead of print. PMID: 39348201.

Chardon FM, McDiarmid TA, Page NF, Daza RM, Martin BK, Domcke S, Regalado SG, Lalanne JB, Calderon D, Li X, Starita LM, Sanders SJ, Ahituv N, Shendure J. Multiplex, single-cell CRISPRa screening for cell type specific regulatory elements. Nat Commun. 2024 Sep 18;15(1):8209. doi: 10.1038/s41467-024-52490-4. PMID: 39294132; PMCID: PMC11411074.

Debroy P, Barrett BW, Erlandson KM, Budoff M, Brown TT, Price JC, Post WS, Stosor V, Skavarca C, D'Souza G, Lake JE. Relationships Between Hepatic Steatosis and Frailty Differ by HIV Serostatus. J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):165-171. doi: 10.1097/QAI.0000000000003477. PMID: 39250650.

Fung M, La Hoz RM, Durand CM, Lee DH, Sears D, Hohe C, Chin-Hong P, Roberts JP. Successful living donor liver transplant from donor with false-positive human immunodeficiency virus test in recipient without human immunodeficiency virus. Am J Transplant. 2024 Sep;24(9):1706-1707. doi: 10.1016/j.ajt.2024.04.021. Epub 2024 May 4. PMID: 38705516.

Gupta N, Hiebert L, Saseetharran A, Chappell C, El-Sayed MH, Hamid S, Jhaveri R, Judd A, Kushner T, Badell M, Biondi M, Buresh M, Prasad M, Price JC, Ward JW. Best practices for hepatitis C linkage to care in pregnant and postpartum women: perspectives from the Treatment In Pregnancy for Hepatitis C Community of Practice. Am J Obstet Gynecol. 2024 Oct;231(4):377-385. doi: 10.1016/j.ajog.2024.06.028. Epub 2024 Jul 2. PMID: 38960017.

IGVF Consortium (Ahituv N). Deciphering the impact of genomic variation on function. Nature. 2024 Sep;633(8028):47-57. doi: 10.1038/s41586-024-07510-0. Epub 2024 Sep 4. PMID: 39232149.

Jain AK, Busgang SA, Gennings C, Yates KP, Schwimmer JB, Rosenthal P, Murray KF, Molleston JP, Scheimann A, Xanthakos SA, Behling CA, Carpenter D, Fishbein M, Neuschwander-Tetri BA, Tonasia J, Vos MB. Environmental toxicants modulate disease severity in pediatric metabolic dysfunction-associated steatohepatitis. J Pediatr Gastroenterol Nutr. 2024 Sep 16. doi: 10.1002/jpn3.12346. Epub ahead of print. PMID: 39282813.

Jin M, Seed RI, Cai G, Shing T, Wang L, Ito S, Cormier A, Wankowicz SA, Jespersen JM, Baron JL, Carey ND, Campbell MG, Yu Z, Tang PK, Cossio P, Wen W, Lou J, Marks J, Nishimura SL, Cheng Y. Dynamic allostery drives autocrine and paracrine TGF-β signaling. Cell. 2024 Sep 12:S0092-8674(24)00965-6. doi: 10.1016/j.cell.2024.08.036. Epub ahead of print. PMID: 39288764.

Kaplan A, Aby ES, Scott S, Sonnenday C, Fox A, Mathur A, Olthoff K, Heimbach J, Ladin K, Emamaullee J; NALLDIG Consortium (Roberts J). Financial toxicity in living donor liver transplantation: A call to action for financial neutrality. Am J Transplant. 2024 Oct;24(10):1742-1754. doi: 10.1016/j.ajt.2024.05.012. Epub 2024 May 18. PMID: 38763318; PMCID: PMC11439575.

Kone LB, Seok D, Kimble MM, Maker AV, Patil S, Mittal V, Jacobs M. Essential Elements in Synoptic Operative Reports for Hepato-Pancreato-Biliary Cancer Surgery: An HPB/CGSO Training Program Survey. Ann Surg Oncol. 2024 Sep 30. doi: 10.1245/s10434-024-16276-8. Epub ahead of print. PMID: 39349910.

Lai M, Lai JC, Allegretti AS, Patidar KR, Cullaro G. Investigating the Association between Steatotic Liver Disease and CKD in a Nationally Representative Sample. Kidney360. 2024 Sep 5. doi: 10.34067/KID.0000000569. Epub ahead of print. PMID: 39235870.

Li M, Bhoori S, Mehta N, Mazzaferro V. Immunotherapy for hepatocellular carcinoma: The next evolution in expanding access to liver transplantation. J Hepatol. 2024 Oct;81(4):743-755. doi: 10.1016/j.jhep.2024.05.037. Epub 2024 Jun 5. PMID: 38848767.

Li PJ, Shah S, Mehta N. Recent Advances in Liver Transplantation for Hepatocellular Carcinoma. Curr Treat Options Oncol. 2024 Sep;25(9):1153-1162. doi: 10.1007/s11864-024-01247-8. Epub 2024 Aug 1. PMID: 39085572; PMCID: PMC11416390.

Li Z, Chen IC, Centonze L, Magyar CTJ, Choi WJ, Shah S, O'Kane G, Vogel A, De Carlis L, Lerut J, Lai Q, Mehta N, Chen CL, Sapisochin G. Analysis of treatment benefits and prognostic factors for Post-Transplant hepatocellular carcinoma recurrence in a large Euro-American-Asian cohort. Liver Transpl. 2024 Oct 3. doi: 10.1097/LVT.0000000000000501. Epub ahead of print. PMID: 39356515.

Mauro E, Sanduzzi-Zamparelli M, Jutras G, Garcia R, Soler Perromat A, Llarch N, Holguin Arce V, Ruiz P, Rimola J, Lopez E, Ferrer-Fàbrega J, García-Criado Á, Colmenero J, Lai JC, Forner A. Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current Controversies. Cancers (Basel). 2024 Sep 2;16(17):3059. doi: 10.3390/cancers16173059. PMID: 39272917; PMCID: PMC11394545.

Moya-Garzon MD, Wang M, Li VL, Lyu X, Wei W, Tung AS, Raun SH, Zhao M, Coassolo L, Islam H, Oliveira B, Dai Y, Spaas J, Delgado-Gonzalez A, Donoso K, Alvarez-Buylla A, Franco-Montalban F, Letian A, Ward C, Liu L, Svensson KJ, Goldberg EL, Gardner CD, Little JP, Banik SM, Xu Y, Long JZ. A secondary β-hydroxybutyrate metabolic pathway linked to energy balance. bioRxiv [Preprint]. 2024 Sep 9:2024.09.09.612087. doi: 10.1101/2024.09.09.612087. PMID: 39314488; PMCID: PMC11418978.

Nobel YR, Boike JR, Mazumder NR, Thornburg B, Hoffman R, Kolli KP, Fallon M, Lai JC, Morelli G, Spengler EK, Said A, Desai AP, Paul S, Goel A, Hu K, Frenette C, Gregory D, Padilla C, Zhang Y, VanWagner LB, Verna EC; Advancing Liver Therapeutic Approaches (ALTA) Study Group. Predictors of long-term clinical outcomes after TIPS: An ALTA group study. Hepatology. 2024 Sep 10. doi: 10.1097/HEP.0000000000001091. Epub ahead of print. PMID: 39255519.

Qi L, Groeger M, Sharma A, Goswami I, Chen E, Zhong F, Ram A, Healy K, Hsiao EC, Willenbring H, Stahl A. Adipocyte inflammation is the primary driver of hepatic insulin resistance in a human iPSC-based microphysiological system. Nat Commun. 2024 Sep 12;15(1):7991. doi: 10.1038/s41467-024-52258-w. PMID: 39266553; PMCID: PMC11393072.

Sardh E, Balwani M, Rees DC, Anderson KE, Jia G, Sweetser MT, Wang B. Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension study. Orphanet J Rare Dis. 2024 Oct 3;19(1):365. doi: 10.1186/s13023-024-03284-w. PMID: 39363243; PMCID: PMC11448181.

Shifman HP, Hatchett J, Pai RA, Safer R, Gomel R, Vyas M, Li M, Lai JC, Wadhwani SI. Caregiver-reported symptom burden and preferences for therapeutic goals in pediatric primary sclerosing cholangitis. J Pediatr Gastroenterol Nutr. 2024 Oct;79(4):835-840. doi: 10.1002/jpn3.12287. Epub 2024 Jun 20. PMID: 38899591; PMCID: PMC11444895.

Tabrizian P, Holzner M, Ajmera V, Kim AK, Zhou K, Schnickel GT, Torosian K, Hoteit M, Marino R, Li M, Yao F, Florman SS, Schwartz ME, Mehta N. Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: the multicenter VITALITY study. J Hepatol. 2024 Sep 8:S0168-8278(24)02541-8. doi: 10.1016/j.jhep.2024.09.003. Epub ahead of print.PMID: 39255928.

Wang M, Shui AM, Ruck J, Huang CY, Verna EC, King EA, Ladner DP, Ganger D, Kappus M, Rahimi R, Tevar AD, Duarte-Rojo A, Lai JC. Clinically relevant cut-points for changes in the Liver Frailty Index are associated with waitlist mortality in patients with cirrhosis. Liver Transpl. 2024 Oct 1;30(10):991-1001. doi: 10.1097/LVT.0000000000000418. Epub 2024 Jun 21. PMID: 38900010.